Medtronic plc (NYSE: MDT ) is scheduled to report first-quarter and fiscal 2023 results on Aug 23, before the opening bell. In the last reported quarter, the company''s earnings lagged the Zacks Consensus Estimate by 2.56%. Medtronic surpassed estimates in three of the trailing four quarters and missed in one, the average surprise being 1.83%. Let''s see how things have shaped up prior to this announcement. Factors at Play Medtronic witnessed an adverse trend of procedure volume across its core business over the past few quarters, impacted by the choppy macroeconomic scenario globally. Per the company''s May 2022 update, the full impact of inflation with increased freight expense will be realized in Q1 and Q2 of fiscal 2023. Further, challenges related to the global supply chain as well as extended COVID-led restrictions in China are expected to have impacted the company''s major business lines. In this regard, in fiscal Q4, Medtronic particularly faced raw material shortages within the Surgical Innovations arm resulting in large backorders.

Learn the story of how Medtronic, one of the world''s largest medical equipment and therapies suppliers, generates money and about Medtronic’s global business.

Medtronic (NYSE: MDT ) will host a conference call at 08:00 AM ET on August 23, 2022, to discuss Q1 2023 earnings results. How to Attend Medtronic (MDT) Conference Call Follow this link to access the live webcast. To listen to the call, dial (US) or (International) What Is an Earnings Conference Call? Earnings conference … Full story available on Benzinga.com

Dr. Laura Mauri faced a monumental moment with former Medtronic CEO Omar Ishrak shortly after she joined the company as VP of global clinical research and analytics. It was late 2018, and Mauri — who’s now an SVP and the chief scientific, medical and regulatory officer at Medtronic (NYSE: MDT) — was in a meeting…

Acutus Medical (Nasdaq:AFIB) this week posted second-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates. The Carlsbad, California-based company reported profits of $5.7 million, or 16¢ per share, on sales of $4.1 million for the three months ended June 30, for a bottom-line gain of 119.9% on sales loss of 13.44% […]

Abbott (NYSE:ABT) will spend €440 million ($450 million) to expand its operations in Ireland, the country’s government announced today. The investment involves the creation of a new 250,000-square-foot manufacturing facility in Kilkenny and a further investment in the company’s Donegal Diabetes Care site. The investment will add 1,000 new jobs between the sites. The new […]

Acutus Medical (Nasdaq:AFIB) this week posted second-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Carlsbad, California-based company reported profits of $5.7 million, or 16¢ per share, on sales of $4.1 million for the three months ended June 30, for a bottom-line gain of 119.9% on sales loss of […]

Medtronic plc. found using ticker (MDT) now have 23 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 142.3 and 85 with the average target price sitting at 110.88. Given that the stocks previous close was at 93.1 this indicates there is a potential upside of 19.1%. There is a 50 day moving average of 91.53 and the 200 day moving average is 104.03. The company has a market capitalisation of $125,770m. Company Website: https://www.medtronic.com [stock_market_widget type="chart" template="basic" color="green" assets="MDT" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $149,789m based on the market concensus. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Medtronic (NYSE: MDT) is recalling 22,110 Cobalt and Crome implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) in the U.S. The Class I recall — the most serious classification from the FDA — is due to the potential for reduced shock energy during high-voltage therapy for Cobalt and Crome ICDs and CRT-Ds, according […]

DUBLIN, Aug. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its first quarter of fiscal year 2023 on Tuesday, August 23, 2022. A news release will be issued at approximately 5:45 a.m….

Mumbai (Maharashtra) [India], August 9 (ANI/BusinessWire India): India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE:MDT) today announced the launch of innovative computer-aided polyps detection system powered by artificial intelligence (AI) — the GI GeniusTM intelligent endoscopy module. A transformative solution that leans on deep learning algorithms and real-time data, the module […]

Published on August 9th, 2022 by Josh Arnold Often, when scanning lists of stocks with great dividend longevity, one will find healthcare companies feature heavily. In general, healthcare companies offer inherent defensiveness, and therefore earnings stability, a combination that makes for the capability to be a great dividend stock. Healthcare companies tend to be more […] The post Blue Chip Stocks In Focus: Medtronic plc appeared first on Sure Dividend .

Intubation Market to Gain Acceleration from Rising Burden of Surgical Procedures; Set for US$ 1.3 Bn Revenue in 2030. Persistence Market Research predicts that the global intubation market will exhibit a 5% CAGR during the forecast period (2020-2030). Get Sample Copy

The newly developed medical solution gives real-time data and empowers physicians to detect and treat colorectal cancer by offering enhanced visualization during colonoscopy

Wells Fargo downgraded Tandem Diabetes Care (Nasdaq:TNDM) as competitors apply pressure to the automated insulin delivery technology developer. According to SeekingAlpha, analysts led by Larry Biegelsen moved Tandem from “Overweight” to “Underweight” due to bullish expectations on Wall Street as the company’s competition, including Insulet and Medtronic, come to the fore. The street responded in kind, with shares […]

New Jersey, USA -- ( SBWIRE ) -- 08/08/2022 -- The latest study released on the Global Kyphoplasty Market by AMA Research evaluates market size, trend, and forecast to 2027. The Kyphoplasty market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in This Report Include: Stryker (United States), Medtronic Inc. (Ireland), Smith & Nephew (United Kingdom), MicroPort Scientific Corporation (China), DePuy Synthes (United States), IZI Medical Products (United States), CareFusion (United States), Merit Medical Systems (United States), joimax GmbH (United States) and G21 S.r.l. (Italy) Download Sample Report PDF (Including Full TOC, Table & Figures) @ https://www.advancemarketanalytics.com/sample-report/200796-global-kyphoplasty-market Definition: Kyphoplasty is the standard surgical treatment for vertebral compression fractures.

During a plea hearing Thursday in U.S. District Court in Minnesota, Farahan admitted he was visiting his friend, Doron“ Ron” Tavlin, in Minneapolis in 2018 when Tavlin gave him information about Medtronic’ s potential acquisition of Mazor Robotics. In the month that followed, Farahan bought over $1 million in Mazor stock; after the Mazor sale was announced, he sold…

A California man faces 24-30 months in prison after pleading guilty to conspiracy to engage in insider trading involving a 2018 Medtronic acquisition.

Medtronic plc. with ticker code (MDT) have now 23 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 142.3 and 85 with a mean TP of 111.32. With the stocks previous close at 93.21 this is indicating there is a potential upside of 19.4%. There is a 50 day moving average of 92.46 while the 200 day moving average is 104.74. The market cap for the company is $124,593m. You can visit the company''s website by visiting: https://www.medtronic.com [stock_market_widget type="chart" template="basic" color="green" assets="MDT" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $148,801m based on the market concensus. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage…

Medtronic (NYSE:MDT) announced today that it partnered with actress Jennifer Stone to help raise awareness on diabetes technology. Stone, best known for portraying “Harper Finkle” on Disney Channel’s Wizards of Waverly Place,” will work with Medtronic Diabetes to help others with type 1 diabetes learn more about the technologies that can make life with the […]

Mitsubishi Electric Automation, Inc.’s new Economy Solutions are packaged servo and motion bundles that allow for high precision motion control in a way that is quick and affordable to integrate. They allow OEMs and system integrators to build budget-friendly machines with advanced motion control and IoT technology. Three different bundles are currently available – compact […]

The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only…

The global wearable injectors market was valued at USD 5.3 billion in 2021 and it is anticipated to grow up to USD 21.7 billion by 2031, at a CAGR of 13.3% during the forecast period. New York, According to a new

This Global Autotransfusion Devices Market assessment by insightSLICE evaluates past and present economic prospects and trends for the years 2022 to 2032 to provide significant insight into key market drivers. There is wide acceptance of Autotransfusion Devices across the buyers''

“Play small and play big” was one of CEO Geoff Martha’s mantras as he and his team reorganized Medtronic (NYSE:MDT), the biggest corporation in medtech. The multi-year effort decentralized Medtronic’s three big groups — cardiology, neuroscience and medical surgical — into 20 narrowly focused operating units (OUs). “The OUs can maintain focus and accountability, execute…

Fueled by personal experience, Maribel Baker leads Medtronic’s diabetes business toward improving health equity. At 15 years old, Maribel Baker’s life was in the balance. While growing up in Panama, Baker had to undergo leg surgery because she was born with one leg shorter than the other. Following the surgery, she learned that she had […]

“Play small and play big” was one of CEO Geoff Martha’s mantras as he and his team reorganized Medtronic (NYSE:MDT), the biggest corporation in medtech. The multi-year effort decentralized Medtronic’s three big groups — cardiology, neuroscience and medical surgical — into 20 narrowly focused operating units (OUs). “The OUs can maintain focus and accountability, execute…

Fueled by personal experience, Maribel Baker leads Medtronic’s diabetes business toward improving health equity. At 15 years old, Maribel Baker’s life was in the balance. While growing up in Panama, Baker had to undergo leg surgery because she was born with one leg shorter than the other. Following the surgery, she learned that she had […]

Medtronic’s subsidiary Covidien issued a Class I recall of millions of its Palindrome and Mahurkar hemodialysis catheters. Covidien issued the recall due to a catheter hub defect that will connect both extension catheters. The defect could leak within the hub of a chronic dialysis catheter, which can lead to mixing of the arterial and venous […]

Medtronic plc. found using ticker (MDT) have now 23 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 142.3 and 85 calculating the mean target price we have 111.32. With the stocks previous close at 91.9 this is indicating there is a potential upside of 21.1%. There is a 50 day moving average of 93.52 and the 200 day MA is 105.52. The company has a market capitalisation of $123,862m. Visit the company website at: https://www.medtronic.com [stock_market_widget type="chart" template="basic" color="green" assets="MDT" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $150,037m based on the market concensus. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet are the largest orthopedic device companies. [Adobe Stock image] With elective procedure numbers rebounding after the darkest days of the COVID-19 pandemic, sales at most of the world’s largest orthopedic device companies increased by double-digit percentages during their most recent fiscal years. Here are the world’s […]

Yesterday US President Joe Biden had a virtual meeting on the Chips Act with the CEOs of Lockheed Martin, Cummins and Medtronic and Commerce Secretary Gina Raimondo. “Congress must pass this bill as soon as possible,” said Biden “there is an economic imperative. This bill is going to supercharge efforts to make semiconductors.” The bill … The post Biden pushes for Chips Act appeared first on Electronics Weekly .

WASHINGTON : US President Joe Biden met virtually yesterday (July 25) with the chief executives of Lockheed Martin Corp, Medtronic PLC and Cummins Inc along with labour leaders as part of the administration’s push for legislation to boost the US semiconductor industry. “Congress must pass this bill as soon as possible,” Biden said. “There is an economic imperative … This bill is going to supercharge efforts to make semiconductors.” The Senate’s Democratic majority leader, Chuck Schumer, said he was delaying a procedural vote because of severe weather issues until today. The bill includes about US$52 billion (RM231 billion) in subsidies for US semiconductor production, as well as a new, four-year 25% tax credit to encourage companies to build US semiconductor plants. The tax credit is estimated to be worth US24 billion. Other provisions include a US$1 billion grant program for “persistently distressed communities”. Last week, the Senate backed by 64 to 34 a procedural measure on a slimmed-down version of legislation.

ReCor Medical and Otsuka Medical Devices today announced positive results from a trial of its renal denervation system for hypertension. The Radiance II U.S. FDA investigational device exemption (IDE) pivotal trial evaluating the Paradise ultrasound renal denervation (uRDN) system as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant reduction in […]

WASHINGTON — President Joe Biden met virtually on Monday with the chief executives of Lockheed Martin Corp, Medtronic PLC and Cummins Inc along with labor leaders as part of the administration’s push for legislation to boost the U.S. semiconductor industry. “Congress must pass this bill as soon as possible,” Biden said. “There is an economic […]

WASHINGTON — President Joe Biden met virtually on Monday with the chief executives of Lockheed Martin Corp, Medtronic PLC and Cummins Inc along with labor leaders as part of the administration’s push for legislation to boost the U.S. semiconductor industry. “This is about investing in the United States,” said Commerce Secretary Gina Raimondo who took […]

As part of the White House push for legislation to support the U.S. semiconductor industry, President Joe Biden is meeting virtually on Monday with the chief executives of Lockheed Martin Corp (NYSE: LMT ), Medtronic PLC (NYSE: MDT ), and Cummins Inc (NYSE: CMI ), as well as labor leaders, according to Reuters. The topic of discussion is focused on Biden’s call on the various companies to support the passage of the CHIPS Act and FABS Act , both of which incentivize U.S. semiconductor companies to … Full story available on Benzinga.com

Lab automation specialist Beckman Coulter Life Sciences has appointed Cardinal Health veteran Suzanne Foster as president. Foster served as Cardinal Health’s President Health-at-Home subsidiary from January 2020 to March 2022. She has more than 25 years of experience in the healthcare industry, and also sits on the boards of several companies. Foster has also served…

iRhythm Technologies (Nasdaq:IRTC) announced today that it appointed a new chief financial officer and a new chief human resources officer. The San Francisco-based wearable electrocardiogram monitors developer will bring in Brice Bobzien as CFO and Reyna Fernandez as EVP and chief human resources officer (CHRO). Fernandez’s appointment was made effective today, while Bobzien will join […]

The American Diabetes Association (ADA) and DaVita today announced the joint launch of an interactive digital experience. ADA and DaVita’s offering aims to help those living with diabetes to prevent and manage kidney disease. ADA launched the new kidney care education section under “Living with Diabetes” on its website in an effort to provide the […]

Lab automation specialist Beckman Coulter Life Sciences has appointed Cardinal Health veteran Suzanne Foster as president. Foster served as Cardinal Health’s President Health-at-Home subsidiary from January 2020 to March 2022. She has more than 25 years of experience in the healthcare industry, and also sits on the boards of several companies. Foster has also served…

Advanced technology in spinal surgery is helping the company build its case in a fast-growing market.

Medtronic stock has been battered over the past year. However, we believe it has formed a significant long-term bottom. Click here to read why.

Medtronic is the world’s largest pure-play medical device company. It is a dividend aristocrat, conservatively financed and well diversified.

Medtronic plc. with ticker code (MDT) have now 23 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 142.3 and 85 calculating the average target price we see 111.32. With the stocks previous close at 90.33 this would imply there is a potential upside of 23.2%. There is a 50 day moving average of 94.47 and the 200 day moving average is 106.38. The market cap for the company is $118,561m. You can visit the company''s website by visiting: https://www.medtronic.com [stock_market_widget type="chart" template="basic" color="green" assets="MDT" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $146,111m based on the market concensus. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Wednesday''s top analyst upgrades and downgrades included Apollo Global Management, Asana, Block, Caesars Entertainment, Dollar General, Gilead Sciences, Goldman Sachs, Invitation Homes, Medtronic, Microsoft, Ovintiv, Plains All American Pipeline, Pioneer Natural Resources and Sunnova Energy.

The FDA has added automated external defibrillators (AEDs), chest drains/suction canisters and autotransfusion systems to its list of medical devices in short supply. AEDs — including wearable and nonwearable versions of the devices — are expected to be in limited supply for at least the rest of 2022, the FDA said. The agency cited both…

From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With […]

Coherent Market Insights has released a new research study on the "Transcatheter Heart Valve Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Transcatheter Heart Valve Market Report detailed information

It’s about figuring out how and where to go with the cardiac ablation and then engineering the best catheter-based delivery device, according to a top Acutus Medical scientist. Cardiac ablation is when a physician intentionally destroys a small amount of tissue in the heart to treat and prevent heart rhythm problems. The procedure creates therapeutic…

The Measuring Division of Kaman Precision Products, Inc. precision non-contact position measuring systems, announces the availability of its improved ThreadChecker. This line of non-contact application-specific sensors provides rugged, reliable verification of thread presence or absence in nearly any electrically conductive material. The ThreadChecker is a teachable eddy current inspection tool, widely used for thread detection, […]

It’s about figuring out how and where to go with the cardiac ablation and then engineering the best catheter-based delivery device, according to a top Acutus Medical scientist. Cardiac ablation is when a physician intentionally destroys a small amount of tissue in the heart to treat and prevent heart rhythm problems. The procedure creates therapeutic…

Medtronic stock reached its 52-week low this week. Click here to see why I think the sell-off is a good buying opportunity for dividend growth investors.

New York, United States, July 15, 2022 (GLOBE NEWSWIRE) -- The factors driving the market are the escalating number of injuries due to sports, governments promoting sports among the public for a healthier lifestyle, and in turn, a rising number of professional athle tes. Important Insights into the Sports Medicine Market The body repair and reconstruction category dominated the product segment. Knee injuries dominated the application segment of the market. Hospitals are the largest contributor to the end-user segment. North America dominated the regional segment. To get a first-hand overview of the report, Request a Sample at https://www.strategicmarketresearch.com/request-sample/sports-medicine-market Report Coverage Details Forecast Period 2020-2030 Forecast Period 2020 to 2030 CAGR 6.2% 2030 Value Projection USD 11.86 Billion Base Year 2020 Market Size in 2020 USD 6.5 Billion Historical Data for 2015 - 2019 No. of Pages 135 Companies Braun Melsungen AG, Hanger Inc, Johnson & Johnson Services, Inc, Arthrex Inc. (US), AlloSource, Novartis AG, Smith & Nephew plc , Surgalign, Össur, Medtronic,Mueller Sports Medicine, Inc.

Galway Bay fm newsroom – Tánaiste Leo Varadkar has praised the role of Medtronic in driving Ireland’s medtech sector as he announced 200 jobs in the city. The jobs are described as high-calibre and diverse, with roles including biomechanical and biomedical engineers, data experts, pharmacists and chemists. It builds on a workforce of more than […]

Medtronic will expand its presence in Galway, with the creation of 200 research and development roles.

Medtronic is at an ‘interesting point’ regarding the overlap of digital and traditional medtech, said its senior R&D director Ronan Rogers. The post Medtronic to create 200 new R&D jobs at Galway facility appeared first on Silicon Republic .

Medtech giant sees Parkmore site as centre of excellence for group’s global cardiac and vascular businesses

Medtronic (NYSE:MDT) and the American Society for Gastrointestinal Endoscopy (ASGE) today announced a program expansion. With support from Amazon Web Service’s (AWS) Health Equity Initiative, Medtronic and ASGE are expanding the Medtronic Health Equity Assistance Program for colon cancer screening in medically underserved communities across the U.S., increasing GI Genius units (provided as part of […]

A cardiologist at Acutus Medical goes over the potential challenges of developing cardiac ablation devices to deliver life-saving treatment to patients. Cardiac ablation is a process in which a physician intentionally destroys a small amount of tissue in the heart to treat and prevent heart rhythm problems. The procedure creates therapeutic scars in the heart […]

Medtronic (NYSE:MDT) will reportedly be adding 200 research and development positions in Galway, Ireland. According to a report in The Independent, the medtech giant has already filled more than half of the R&D roles, which come as part of a $30 million investment. “These roles will support the development of products and services in the coronary […]

Medtronic (NYSE:MDT) and the American Society for Gastrointestinal Endoscopy (ASGE) today announced a program expansion. With support from Amazon Web Service’s (AWS) Health Equity Initiative, Medtronic and ASGE are expanding the Medtronic Health Equity Assistance Program for colon cancer screening in medically underserved communities across the U.S., increasing GI Genius units (provided as part of […]

Medtronic (NYSE:MDT) will reportedly be adding 200 research and development positions in Galway, Ireland. According to a report in The Independent, the medtech giant has already filled more than half of the R&D roles, which come as part of a $30 million investment. “These roles will support the development of products and services in the coronary […]

Medtronic (MDT) on Thursday said it had got a medical device clearance from the U.S. FDA for its UNiD Spine Analyzer v4.0 planning platform

Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe to warn of issues with some implantable cardioverter defibrillators (ICDs). The medtech giant warned healthcare professionals that there is the potential for reduced shock energy — around 79% of programmed energy — during high-voltage (HV) therapy for all Cobalt and Crome ICDs and cardiac resynchronization […]

Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its UNiD spine analyzer v4.0 planning platform. The UNiD spine analyzer v4.0 includes a new Degen algorithm for degenerative spine procedures, with the algorithm designed to leverage machine learning to help surgeons plan and personalize procedures for patients undergoing lower lumbar spine surgery and […]

Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe to warn of issues with some implantable cardioverter defibrillators (ICDs). The medtech giant warned healthcare professionals that there is the potential for reduced shock energy — around 79% of programmed energy — during high-voltage (HV) therapy for all Cobalt and Crome ICDs and cardiac resynchronization […]

Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its UNiD spine analyzer v4.0 planning platform. The UNiD spine analyzer v4.0 includes a new Degen algorithm for degenerative spine procedures. The algorithm is designed to leverage machine learning to help surgeons plan and personalize procedures for patients undergoing lower lumbar spine surgery and […]

Medical device maker Medtronic (MDT) hit a 52-week low of $86.81 in Wednesday trading. Year to date, shares are down 17%.

Longenesis announced today that a study on type 1 diabetes care, in partnership with Medtronic (NYSE:MDT), supports insulin pump use. Across less than three months, more than 85 patients participated in the research study aimed at providing qualitative and quantitative data on the quality of life for type 1 diabetics using insulin pumps compared to […]

US-Irish healthcare tech giant to invest $75 million in Kfar Saba-headquartered outfit, the developer of a diagnostic tool for coronary artery disease

As part of the agreement, Medtronic will invest up to $75 million in the Israeli med-tech company, which has developed a diagnostic system that helps doctors evaluate the severity of coronary artery disease.

The medical device giant has held since 2018 a minority investment in CathWorks, which develops non-invasive diagnostic alternatives to catheters

FRIDLEY (dpa-AFX) - Healthcare technology firm Medtronic plc (MDT) announced Tuesday it has entered into a strategic partnership agreement with Israeli privately-held company CathWorks, which aims…

HTF Market Intelligence released a new research report of 182 pages on title ''eHealth Devices Market: Current Analysis and Forecast (2022-2030)'' with detailed analysis, forecast and strategies. The study is a perfect mix of qualitative and quantitative Market data collected

HTF Market Intelligence released a new research report of 234 pages on title ''Medical Disposables Market: Current Analysis and Forecast (2022-2030)'' with detailed analysis, forecast and strategies. The study is a perfect mix of qualitative and quantitative Market data collected

Medtronic (NYSE:MDT) announced today that it entered into a strategic partnership with coronary artery disease (CAD) technology developer CathWorks. Under the agreement, Medtronic will invest up to $75 million and immediately begin co-promotion for CathWorks’ FFRangio system in the U.S. Europe and Japan, where it is commercially available. A separate agreement offers Medtronic the option […]

Cerus Endovascular today announced the appointment of Stephen Griffin to chief executive officer, effective immediately. Griffin has been with the company since 2014 and has served as president since 2018. He played a critical role in assembling the current Fremont, California-based company’s team and helped establish the Contour brand internationally. “Stephen played a vital role […]

Medtronic (NYSE:MDT) announced today that it entered into a strategic partnership with coronary artery disease (CAD) technology developer CathWorks. Under the agreement, Medtronic will invest up to $75 million and immediately begin co-promotion for CathWorks’ FFRangio system in the U.S. Europe and Japan, where it is commercially available. A separate agreement offers Medtronic the option […]

The trio of friends are charged both criminally and civilly for their actions, which federal authorities say made them around $500,000.

Ganymed Robotics’ technology platform acts as a co-manipulated robotic assistant for total knee arthroplasty.

A former Mazor Robotics VP is among three businessmen facing federal insider trading charges and an SEC lawsuit over stock trades leading up to Medtronic’s $1.6 billion acquisition announcement in 2018. Ron Tavlin was Mazor’s VP of business development from 2017 to 2019. Before that, he’d been a paid consultant for Medtronic. The U.S. Attorney’s […]

Ron Tavlin allegedly informed a friend about Medtronic’s impending acquisition announcement of Mazor Robotics in 2018.

A former Mazor Robotics VP is among three businessmen facing federal insider trading charges and an SEC lawsuit over stock trades leading up to Medtronic’s $1.6 billion acquisition announcement in 2018. Ron Tavlin was Mazor’s VP of business development from 2017 to 2019. Before that, he’d been a paid consultant for Medtronic. The U.S. Attorney’s […]

“Tavlin tipped Farahan that Mazor was about to be acquired, that Farahan should purchase shares quickly, and that the information was confidential. Tavlin told Farahan he could be fired for providing Farahan with this information. During the same trip, Farahan was at his luxury rug store in Bloomington discussing stocks with a mutual friend, David Gantman, a 56-…

A Minneapolis business executive and friends from Mendota Heights and California allegedly profited.

Allied Market Research added new research on France Regenerative Medicine Market- Opportunity Analysis and Industry Forecast, 2022-2030. The Regenerative Medicine market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The

The documentation of the market research report contains various market analysis strategies that are involved to study the Global Bone Tumor Ablation Devices Market such as PESTLE analysis, SWOT analysis and Five point analysis. All these strategies will help the